Wave Life Sciences Ltd. (NASDAQ:WVE) released data from the Phase 2 FORWARD-53 trial of WVE-N531, which is an exon-skipping oligonucleotide being investigated in boys with Duchenne muscular dystrophy ...
Micro-jumping robots offer unique advantages in scenarios such as confined space exploration and post-disaster search and rescue. However, traditional designs have consistently faced two major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results